|Articles|June 30, 2021

COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of June 30, 2021

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 vaccinations, cases, and deaths in the US and on cases and deaths worldwide.

How many people in the US have been vaccinated against COVID-19?

According to the US Centers for Disease Control and Prevention, as of today, June 30, 2021, at 4:07 PM, EDT:

• 54.4% of total US population has received at least 1 dose
• 46.7% of total US population is fully vaccinated

The 5 states with the highest percentage of population fully vaccinated are:

1. Vermont: 65.6%
2. Massachusetts: 61.6%
3. Maine: 61%
4. Connecticut: 60.7%
5. Rhode Island: 58.9%

How many cases of COVID-19 have been confirmed in the US?

According to the Johns Hopkins COVID-19 interactive map, as of today, June 30, 2021 at 3:24 PM, EDT, there have been:

• 33 659 062 confirmed cases
• 604 623 deaths

The 5 states with the highest total confirmed cases are:

1. California: 3 818 024
2. Texas: 2 997 450
3. Florida: 2 365 464
4. New York: 2 114 986
5. Illinois: 1 391 740

Deaths: California has the most deaths due to COVID-19 with 63 639 reported fatalities, followed by New York with 53 678, and Texas with 52 313.

How many cases of COVID-19 have been confirmed globally?

Globally, there have been 181 996 280 confirmed cases, 3 941 377 deaths, and 3 040 111 880 vaccine doses administered.

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Related to this article

September 3rd, 2026

FDA Approves Pfizer-BioNTech XFG-Adapted COVID-19 Vaccine for 2026-27 Season

FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.

September 2nd, 2026

Independent Review Supports Respiratory Virus Immunizations for 2026-27 Season

A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.

August 25th, 2026

Pre-Vaccine Antibodies May Predict Blunted COVID-19 Vaccine Response

Pre-existing antibodies to common microbes predicted COVID-19 vaccine response strength in healthy and immunosuppressed adults.

August 31st, 2026

FDA Approves Bixlenvo for HIV-1 Switch Therapy in Virologically Suppressed Adults

FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.

August 26th, 2026

FDA Expands Dolutegravir Approval to Infants With HIV-1 Weighing at Least 2 kg

FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.

August 11th, 2026

New Childhood Vaccine Executive Order Draws Criticism From AAP, AMA, NFID

The organizations challenge a presidential executive order narrowing routine childhood vaccine recommendations and urging vaccines to be given separately.